Top Banner
Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital
28

Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Dec 22, 2015

Download

Documents

Arthur Owens
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Testicular Cancers

Ashray GunjurIntern, Royal Melbourne Hospital

Page 2: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Did you know?

• That the words testify, testimonial and testament are derived from...

Page 3: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Anatomy

http://www.aboutcancer.com/testicle_anatomy1.jpg

Page 4: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Differentials

HISTORY?* Pain??* Time course of symptoms?

PHYSICAL EXAM?* pain?* reducibility?* Lie of teste?

Page 5: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Differentials

Toronto Notes 2010

Page 7: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Differentials

• 2) Epidydymal cyst/Spermatocele

Page 8: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Differential

• 3) Varicocele

Page 9: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Typical case

• Young man with painless growth of unilateral teste

• On examniation, firm nontender, non-transilluminating mass in one of the testes

Page 10: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Epidemiology

• Relatively rare- 1-2% of men, but..• Most common malignancy in age 20-40• Three peak model: infancy, 30-34 years, >60

years

Page 11: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Risk factors

• Cryptorchidism- 4-8x risk of germ cell tumour– Risk still increased after orchiopexy in pt <6yrs old-

2.23x*– Risk still increased in contralateral testis- 5-20% of

malignancy in normal descended testis!• Prior testicular cancer- 500x– Approx 1-2% of testicular cancer patients will

develop a second primary contralaterally...

*Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. May 3 2007;356(18):1835-41

Page 12: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Risk factors

• Genetics– E.g. Klinefelter syndrom (47XXY)- germ cell

tumours• Diethylstilbestrol (DES) exposure in utero– E.g. ‘Agent Orange’, Industrial occupation

Page 13: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Diagnosis

• Best first testhypoechoic lesion

Page 14: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Diagnosis

• Gold standard?

- inguinal orchidectomy!!

Page 15: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Histologic types

Germ cell tumors (>95%):Seminoma (40%) versus Non seminomatous germ

cell tumors (NSGCT) (40%) vs. mixed (15%)

Non-germ cell tumors (rare, <5%)Leydig cell tumors (precocious puberty)Sertoli cell tumors Mixed sex chord-stromal tumors

Page 16: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Germ cell tumours

• Seminoma (40%)– Generally favourable prognosis, tend to be in older men– Rarely make B-HCG (15%), no aFP (0%)

• Non-seminoma (40%)– Choriocarcinoma

(elevated b-HCG (50%), haematogenous spread)– Embryonal cell– Teratoma (mature and immature)– Yolk sac

(elevated AFP)

Page 17: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Tumour markers

• AFP levels are elevated 50%-70% NSGCT• hCG levels are elevated in 40%-60% NSGCT. • AFP has a half-life of 5-7 days• hCG has a half-life of 36 hours. • Important to follow response after

orchiectomy• LDH is non-specific measure of tumor burden

Page 18: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Risk stratification• Good-risk nonseminoma• Testicular or retroperitoneal primary tumor, and• No nonpulmonary visceral metastases, and• Good markers; all of:Alpha-fetoprotein (AFP) < 1,000 ng/mL, and• Human chorionic gonadotropin (hCG) < 5,000 IU/mL (1,000 ng/mL), and• Lactate dehydrogenase (LDH) < 1.5 times the upper limit of normal

• Intermediate-risk nonseminoma• Testicular or retroperitoneal primary tumor, and• No nonpulmonary visceral metastases, and• Intermediate markers; any of:AFP 1,000 to 10,000 ng/mL, or• hCG 5,000 IU/L to 50,000 IU/L, or• LDH 1.5 to 10 times the upper limit of normal

• Poor-risk nonseminoma• Mediastinal primary, or• Nonpulmonary visceral metastases, or• Poor markers; any of:AFP > 10,000 ng/mL, or• hCG > 50,000 IU/mL (10,000 ng/mL), or• LDH > 10 times the upper limit of normal

Page 19: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Risk stratification

• Good-risk seminoma• Any primary site, and• No nonpulmonary visceral metastases, and• Normal AFP, any hCG, any LDH• Intermediate-risk seminoma• Any primary site, and• Nonpulmonary visceral metastases, and• Normal AFP, any hCG, any LDH• Poor-risk seminoma• No such thing!!

Page 20: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

TreatmentPost Orchidectomy…

SeminomaStage IA and B: radiation therapy vs surveillance (? Chemo)NSGCTStage IAretroperitoneal lymph node dissection vs surveillanceStage IBretroperitoneal lymph node dissection vs surveillance vs

chemotherapy

Higher stages-chemo, f/b surgery as needed

Page 21: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Retroperitoneal Lymph Node Dissection

Page 22: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Why?

• Non-seminomas are more aggressive than seminomas

• RPLND is used to guide chemotherapy– No of +ive nodes correlates to cycles of chemo

Page 23: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Surveillance

NCCN guidelines• CT q 2-3 months for first year or two• Then q4, q6• Labs, CXR q month for year one, then q 2

months, etc

• Issues are compliance, anxiety

Page 24: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Question 1

The most common presenting complaint for a testicular cancer is:

a) a painless swelling of a single testeb) a red, painful scrotumc) haematuriad) back pain

Page 25: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Question 2

• All of the following are a risk factor for testicular cancers, save

a) Cryptorchidismb) Maternal DES exposurec) Caucasian raced) Repeated testicular trauma

Page 26: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Question 3

The following statements are false, savea) Testicular cancer is the most common cancer of

infancyb) There are more men aged 15-25 diagnosed with

testicular cancer than >50c) Unilateral surgical orchidectomy precludes the

chance of testicular cancer recurringd) Unilateral surgical orchidectomy is the gold

standard diagnostic procedure for testicular cancer

Page 27: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Question 4

Routine workup and staging of diagnosed testicular cancer should include:

a) a-FPb) B-HcGc) CT A/P + Cd) PET scan

Page 28: Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital.

Question 5

The following are incorrect about Seminomas, save

a) Ultrasound features often involve heterogenous cystic components

b) aFP is often raised and used for prognostication

c) Para-aortic radiotherapy is often indicatedd) Patients with metastatic disease have a poor

prognosiss